Showing results (121-130 of 239) with videos related to
Sort By:
Pageof 24
European Journal of Cancer (Oxford, England : 1990)|December 2, 2004
Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck. An EORTC New Drug Development Group studyF Duffaud, M Borner, P Chollet, et al.Frontiers in Behavioral Neuroscience|July 31, 2013
General developmental health in the VPA-rat model of autismMônica R Favre, Tania R Barkat, Deborah Lamendola, et al.Fetal Diagnosis and Therapy|June 12, 1999
In utero fetal muscle biopsy: a precious aid for the prenatal diagnosis of Duchenne muscular dystrophyS Heckel, R Favre, J Flori, et al.Bulletin Du Cancer|January 1, 1990
[Clinical pharmacokinetics of navelbine after oral administration, in vitro metabolism and interindividual variability]Z Sahnoun, X J Zhou, P Bore, et al.European Journal of Cancer & Clinical Oncology|October 1, 1986
6-day subrenal capsule assay (SRCA) as a predictor of the response of advanced cancers to chemotherapyR Favre, L Marotia, M Drancourt, et al.Journal of Pharmaceutical and Biomedical Analysis|January 1, 1984
Assay of methotrexate and 7-hydroxymethotrexate by gradient-elution high-performance liquid chromatography and its application in a high-dose pharmacokinetic studyG Fabre, J P Cano, A Iliadis, et al.Cancer Chemotherapy and Pharmacology|January 1, 1991
Pharmacokinetics of navelbine after oral administration in cancer patientsX J Zhou, P Boré, S Monjanel, et al.Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|December 22, 1999
[Nuchal translucency: screening for chromosomal abnormalities and congenital malformations. Multicenter study]M Jemmali, A S Valat, P Poulain, et al.Journal of Neural Transmission|January 1, 1987
Differential effect of guanethidine on dopamine and norepinephrine pools in urine, heart and superior cervical ganglion in the ratR Favre, M De Haut, C Boudet, et al.Cancer Research|November 1, 1987
Clinical pharmacokinetics of the antitumor drug navelbine (5'-noranhydrovinblastine)R Rahmani, R Bruno, A Iliadis, et al.Pageof 24